TC-Based Company Enters FDA Trials For Long COVID Treatment
Thursday, February 22, 2024
Traverse City’s Dr. Bruce Patterson has been working for years to develop what he claims is the best treatment option available for patients suffering from long-haul COVID. Now, that medication is one step closer to a gamechanging approval from the United States Food and Drug Administration (FDA). Last week, Patterson’s company, called HealthBio AI, announced that it
- Published in Related Press